189 related articles for article (PubMed ID: 1849425)
21. Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow CA; Reardon IM; Chaudhary VK; Fryling CM; Pastan I; Fitzgerald DJ
J Virol; 1990 Jul; 64(7):3157-61. PubMed ID: 2161935
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
[TBL] [Abstract][Full Text] [Related]
23. The Gag-Pol encoded proteinase of an avian retrovirus expressed in E. coli can produce a novel proteinase (PR + IleGly) that is two amino acids larger at its carboxy-terminal region than the major Gag proteinase (PR).
Brynda J; Fábry M; Horejsí M; Sedlácek J
Virology; 1995 Feb; 207(1):185-90. PubMed ID: 7871726
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of recombinant Drosophila Copia aspartic proteinase.
Athauda SB; Yoshioka K; Shiba T; Takahashi K
Biochem J; 2006 Nov; 399(3):535-42. PubMed ID: 16813567
[TBL] [Abstract][Full Text] [Related]
25. Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates.
Tözsér J; Friedman D; Weber IT; Bláha I; Oroszlan S
Biochemistry; 1993 Apr; 32(13):3347-53. PubMed ID: 8384879
[TBL] [Abstract][Full Text] [Related]
26. Substrate specificities and kinetic properties of proteinase A from the yeast Saccharomyces cerevisiae and the development of a novel substrate.
Kondo H; Shibano Y; Amachi T; Cronin N; Oda K; Dunn BM
J Biochem; 1998 Jul; 124(1):141-7. PubMed ID: 9644256
[TBL] [Abstract][Full Text] [Related]
27. Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
Hrusková-Heidingsfeldová O; Bláha I; Urban J; Strop P; Pichová I
Leukemia; 1997 Apr; 11 Suppl 3():45-6. PubMed ID: 9209292
[TBL] [Abstract][Full Text] [Related]
28. Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.
Schatz G; Pichova I; Vogt VM
J Virol; 1997 Jan; 71(1):444-50. PubMed ID: 8985369
[TBL] [Abstract][Full Text] [Related]
29. Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
Richards AD; Phylip LH; Farmerie WG; Scarborough PE; Alvarez A; Dunn BM; Hirel PH; Konvalinka J; Strop P; Pavlickova L
J Biol Chem; 1990 May; 265(14):7733-6. PubMed ID: 2186027
[TBL] [Abstract][Full Text] [Related]
30. In vitro cleavage of avian retrovirus gag proteins by viral protease p15.
Vogt VM; Wight A; Eisenman R
Virology; 1979 Oct; 98(1):154-67. PubMed ID: 90424
[No Abstract] [Full Text] [Related]
31. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
32. Isolation, biochemical characterization and crystallization of the p15gag proteinase of myeloblastosis associated virus expressed in E. coli.
Pichová I; Strop P; Sedlácek J; Kaprálek F; Benes V; Trávnícek M; Pavlícková L; Soucek M; Kostka V; Foundling S
Int J Biochem; 1992 Feb; 24(2):235-42. PubMed ID: 1733789
[TBL] [Abstract][Full Text] [Related]
33. Myeloblastosis associated virus (MAV) proteinase site-mutated to be HIV-like has a higher activity and allows production of infectious but morphologically altered virus.
Sedlacek J; Fabry M; Coward JE; Horejsi M; Strop P; Luftig RB
Virology; 1993 Feb; 192(2):667-72. PubMed ID: 7678476
[TBL] [Abstract][Full Text] [Related]
34. Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.
Tözsér J; Bagossi P; Boross P; Louis JM; Majerova E; Oroszlan S; Copeland TD
Eur J Biochem; 1999 Oct; 265(1):423-9. PubMed ID: 10491200
[TBL] [Abstract][Full Text] [Related]
35. Protein-engineered proteinase of myeloblastosis associated virus, an enzyme of high activity and HIV-1 proteinase-like specificity.
Strop P; Horejsí M; Konvalinka J; Skrabana R; Velek J; Bláha I; Cerná V; Pichová I; Pavlícková L; Andreánsky M
Adv Exp Med Biol; 1991; 306():515-8. PubMed ID: 1812751
[No Abstract] [Full Text] [Related]
36. Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1.
Konvalinka J; Strop P; Velek J; Cerna V; Kostka V; Phylip LH; Richards AD; Dunn BM; Kay J
FEBS Lett; 1990 Jul; 268(1):35-8. PubMed ID: 2200711
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW
J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736
[TBL] [Abstract][Full Text] [Related]
38. Synthetic peptides as substrates and inhibitors of a retroviral protease.
Kotler M; Katz RA; Danho W; Leis J; Skalka AM
Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4185-9. PubMed ID: 2837759
[TBL] [Abstract][Full Text] [Related]
39. Substrate specificities of pepstatin-insensitive carboxyl proteinases from gram-negative bacteria.
Ito M; Dunn BM; Oda K
J Biochem; 1996 Oct; 120(4):845-50. PubMed ID: 8947851
[TBL] [Abstract][Full Text] [Related]
40. Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.
Eizert H; Bander P; Bagossi P; Sperka T; Miklóssy G; Boross P; Weber IT; Tözsér J
J Virol; 2008 Oct; 82(20):10111-7. PubMed ID: 18701588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
